Search research articles
Contact Us
Filters
Showing results (21-30 of 85) with videos related to
Page
of 9
Sort By:
Thrombosis Research
|
November 15, 1986
Anticoagulant activity of anticardiolipin antibodies
F Violi, G Valesini, D Ferro, et al.
Haematologica
|
January 1, 1994
Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study
F Violi, R Leo, S Basili, et al.
Haematologica
|
November 1, 1984
Fibrinopeptide A behaviour in chronic active hepatitis patients
F Violi, C Alessandri, D Ferro, et al.
Lancet (London, England)
|
July 4, 1998
Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia
D Ferro, S Basili, C Alessandri, et al.
Journal of Hepatology
|
December 1, 1994
Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels
C Quintarelli, D Ferro, G Valesini, et al.
Seminars in Thrombosis and Hemostasis
|
April 1, 1989
Inhibition of tissue plasminogen activator inhibitor by defibrotide in atherosclerotic patients
F Violi, D Ferro, C Alessandri, et al.
Thrombosis and Haemostasis
|
August 1, 1996
Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group
F Violl, S Basili, D Ferro, et al.
Journal of Clinical Pathology
|
September 1, 1986
Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease
C Cordova, F Violi, C Alessandri, et al.
Thrombosis Research
|
August 1, 1990
Specificity and sensitivity of diluted aPTT and anticardiolipin antibodies towards thrombosis and miscarriages in patients with systemic lupus erythematosus
D Ferro, M Saliola, C Quintarelli, et al.
European Journal of Clinical Pharmacology
|
January 1, 1992
Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance
F Violi, D Ferro, M Saliola, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 85) with videos related to
Sort By:
Page
of 9
Thrombosis Research
|
November 15, 1986
Anticoagulant activity of anticardiolipin antibodies
F Violi, G Valesini, D Ferro, et al.
Haematologica
|
January 1, 1994
Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study
F Violi, R Leo, S Basili, et al.
Haematologica
|
November 1, 1984
Fibrinopeptide A behaviour in chronic active hepatitis patients
F Violi, C Alessandri, D Ferro, et al.
Lancet (London, England)
|
July 4, 1998
Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia
D Ferro, S Basili, C Alessandri, et al.
Journal of Hepatology
|
December 1, 1994
Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels
C Quintarelli, D Ferro, G Valesini, et al.
Seminars in Thrombosis and Hemostasis
|
April 1, 1989
Inhibition of tissue plasminogen activator inhibitor by defibrotide in atherosclerotic patients
F Violi, D Ferro, C Alessandri, et al.
Thrombosis and Haemostasis
|
August 1, 1996
Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group
F Violl, S Basili, D Ferro, et al.
Journal of Clinical Pathology
|
September 1, 1986
Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease
C Cordova, F Violi, C Alessandri, et al.
Thrombosis Research
|
August 1, 1990
Specificity and sensitivity of diluted aPTT and anticardiolipin antibodies towards thrombosis and miscarriages in patients with systemic lupus erythematosus
D Ferro, M Saliola, C Quintarelli, et al.
European Journal of Clinical Pharmacology
|
January 1, 1992
Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance
F Violi, D Ferro, M Saliola, et al.
Page
of 9